Allena Pharmaceuticals, Inc. - FORM S-1 - EX-23.1 - October 6, 2017

Attached files

file filename
EX-10.11 - EX-10.11 - Allena Pharmaceuticals, Inc.d431688dex1011.htm
EX-21.1 - EX-21.1 - Allena Pharmaceuticals, Inc.d431688dex211.htm
EX-10.12 - EX-10.12 - Allena Pharmaceuticals, Inc.d431688dex1012.htm
EX-10.10 - EX-10.10 - Allena Pharmaceuticals, Inc.d431688dex1010.htm
EX-10.9 - EX-10.9 - Allena Pharmaceuticals, Inc.d431688dex109.htm
EX-10.8 - EX-10.8 - Allena Pharmaceuticals, Inc.d431688dex108.htm
EX-10.4 - EX-10.4 - Allena Pharmaceuticals, Inc.d431688dex104.htm
EX-10.1 - EX-10.1 - Allena Pharmaceuticals, Inc.d431688dex101.htm
EX-5.1 - EX-5.1 - Allena Pharmaceuticals, Inc.d431688dex51.htm
EX-4.4 - EX-4.4 - Allena Pharmaceuticals, Inc.d431688dex44.htm
EX-4.3 - EX-4.3 - Allena Pharmaceuticals, Inc.d431688dex43.htm
EX-4.2 - EX-4.2 - Allena Pharmaceuticals, Inc.d431688dex42.htm
EX-3.4 - EX-3.4 - Allena Pharmaceuticals, Inc.d431688dex34.htm
EX-3.3 - EX-3.3 - Allena Pharmaceuticals, Inc.d431688dex33.htm
EX-3.2 - EX-3.2 - Allena Pharmaceuticals, Inc.d431688dex32.htm
EX-1.1 - EX-1.1 - Allena Pharmaceuticals, Inc.d431688dex11.htm
S-1 - S-1 - Allena Pharmaceuticals, Inc.d431688ds1.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated August 18, 2017, in the Registration Statement (Form S-1) and related Prospectus of Allena Pharmaceuticals, Inc. dated October 6, 2017.

/s/ Ernst & Young LLP

Boston, Massachusetts

October 6, 2017

Allena Pharmaceuticals, Inc. Reports